HIV Resistance Prediction to Reverse Transcriptase Inhibitors: Focus on Open Data
AbstractResearch and development of new antiretroviral agents are in great demand due to issues with safety and efficacy of the antiretroviral drugs. HIV reverse transcriptase (RT) is an important target for HIV treatment. RT inhibitors targeting early stages of the virus-host interaction are of great interest for researchers. There are a lot of clinical and biochemical data on relationships between the occurring of the single point mutations and their combinations in the pol gene of HIV and resistance of the particular variants of HIV to nucleoside and non-nucleoside reverse transcriptase inhibitors. The experimental data stored in the databases of HIV sequences can be used for development of methods that are able to predict HIV resistance based on amino acid or nucleotide sequences. The data on HIV sequences resistance can be further used for (1) development of new antiretroviral agents with high potential for HIV inhibition and elimination and (2) optimization of antiretroviral therapy. In our communication, we focus on the data on the RT sequences and HIV resistance, which are available on the Internet. The experimental methods, which are applied to produce the data on HIV-1 resistance, the known data on their concordance, are also discussed. View Full-Text
- Supplementary File 1:
ZIP-Document (ZIP, 436 KB)
Share & Cite This Article
Tarasova, O.; Poroikov, V. HIV Resistance Prediction to Reverse Transcriptase Inhibitors: Focus on Open Data. Molecules 2018, 23, 956.
Tarasova O, Poroikov V. HIV Resistance Prediction to Reverse Transcriptase Inhibitors: Focus on Open Data. Molecules. 2018; 23(4):956.Chicago/Turabian Style
Tarasova, Olga; Poroikov, Vladimir. 2018. "HIV Resistance Prediction to Reverse Transcriptase Inhibitors: Focus on Open Data." Molecules 23, no. 4: 956.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.